Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-10-29

Clinical Trial Update: Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) on Immune Reconstitution of HIV Patients [NA]

View source ↗

Summary

This document describes a clinical trial evaluating Immunity 1 (Fuzheng 1) for immune reconstitution in HIV/AIDS patients; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Immunity 1 (Fuzheng 1)

Snippet

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Conditions: Acquired Immune Deficiency Syndrome Virus, HIV Infections | NA | Status: UNKNOWN